Congenital neutropenia

Blood Reviews

Volumn 17, Issue 4, 2003, Pages 209-216

  Ancliff, Philip James ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Congenital neutropenia; Elastase; Neutropenia

Indexed keywords

ANTIBIOTIC AGENT; GRANULOCYTE COLONY STIMULATING FACTOR; LEUKOCYTE ELASTASE; PANCREAS ENZYME; WISKOTT ALDRICH SYNDROME PROTEIN;

CLINICAL FEATURE; CLINICAL TRIAL; CONGENITAL NEUTROPENIA; DRUG RESPONSE; GENE MUTATION; GLYCOGEN STORAGE DISEASE TYPE 1; HUMAN; IMMUNE DEFICIENCY; LEUKEMIA; MALIGNANT TRANSFORMATION; NEUTROPENIA; PATHOGENESIS; PEARSON SYNDROME; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SHWACHMAN SYNDROME; SYMPTOM; WISKOTT ALDRICH SYNDROME;

EID: 0242354775     PISSN: 0268960X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-960X(03)00019-5     Document Type: Review

References (77)

1. Dallman PR. Reference ranges for leukocyte counts in children. In: Nathan DG, Orkin SH, eds. Nathan and Oski's Hematology of Infancy and Childhood. Philadelphia: WB Saunders Company; 1998 (Appendices XV).
2. Reed WW, Diehl LF. Leukopenia, neutropenia, and reduced hemoglobin levels in healthy American blacks. Arch Intern Med 1991; 151: 501-505.
3. Sadowitz PD, Oski FA. Differences in polymorphonuclear cell counts between healthy white and black infants: response to meningitis. Pediatrics 1983; 72: 405-407.
4. Dinauer MC. The phagocyte system and disorders of granulopoiesis and granulocyte function. In: Nathan DG, Orkin SH, eds. Nathan and Oski's Hematology of Infancy and Childhood. Philadelphia: WB Saunders Company; 1998: 910.
5. Dinauer MC. The phagocyte system and disorders of granulopoiesis and granulocyte function. In: Nathan DG, Orkin SH, eds. Nathan and Oski's Hematology of Infancy and Childhood. Philadelphia: WB Saunders Company; 1998: 917-918.
6. Maheshwari A, Christensen RD, Calhoun DA. Immune neutropenia in the neonate. Adv Pediatr 2002; 49: 317-339.
7. Lyall EG, Lucas GF, Eden OB. Autoimmune neutropenia of infancy. J Clin Pathol 1992; 45: 431-434.
8. Welte K, Dale D. Pathophysiology and treatment of severe chronic neutropenia. Ann Hematol 1996; 72: 158-165.
9. Bux J, Behrens G, Jaeger G, Welte K. Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. Blood 1998; 91: 181-186.
10. Kostmann R. Infantile genetic agranulocytosis. Acta Paediatr 1956; 45(suppl 105): 1-78.
11. Zeidler C, Welte K. Kostmann syndrome and severe congenital neutropenia. Semin Hematol 2002; 39: 82-88.
12. Mempel K, Pietsch T, Menzel T, Zeidler C, Welte K. Increased serum levels of granulocyte colony-stimulating factor in patients with severe congenital neutropenia. Blood 1991; 77: 1919-1922.
13. Kyas U, Pietsch T, Welte K. Expression of receptors for granulocyte colony-stimulating factor on neutrophils from patients with severe congenital neutropenia and cyclic neutropenia, Blood 1992; 79: 1144-1147.
14. Guba SC, Sartor CA, Hutchinson R, Boxer LA, Emerson SG. Granulocyte colony-stimulating factor (G-CSF) production and G-CSF receptor structure in patients with congenital neutropenia. Blood 1994; 83: 1486-1492.
15. Dong F, Brynes RK, Tidow N et al. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. N Engl J Med 1995; 333: 487-493.
16. Tidow N, Pilz C, Teichmann B et al. Clinical relevance of point mutations in the cytoplasmic domain of the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia. Blood 1997; 89: 2369-2375.
17. Ward AC, van Aesch YM, Gits J et al. Novel point mutation in the extracellular domain of the granulocyte colony-stimulating factor (G-CSF) receptor in a case of severe congenital neutropenia hyporesponsive to G-CSF treatment. J Exp Med 1999; 190: 497-507.
18. Sinha S, Watkins S, Corey SJ. Genetic and biochemical characterization of a deletional mutation of the extra-cellular domain of the human G-CSF receptor in a child with severe congenital neutropenia unresponsive to neupogen [abstract]. Blood 2001; 98: 440a.
19. Horwitz M, Benson KF, Person RE, Aprikyan AG, Dale DC. Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis. Nat Genet 1999; 23: 433-436.
20. Dale DC, Person RE, Bolyard AA et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood 2000; 96: 2317-2322.
21. Ancliff PJ, Gale RE, Liesner R, Hann IM, Linch DC. Mutations in the ELA2 gene encoding neutrophil elastase are present in most patients with sporadic severe congenital neutropenia but only in some patients with the familial form of the disease. Blood 2001; 98: 2645-2650.
22. Germeshausen M, Schulze H, Ballmaier M, Zeidler C, Welte K. Mutations in the gene encoding neutrophil elastase (ELA2) are not sufficient to cause the phenotype of congenital neutropenia. Br J Haematol 2001; 115: 222-224.
23. Ancliff PJ, Gale RE, Watts MJ et al. Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia. Blood 2002; 100: 707-709.
24. Fouret P, du Bois RM, Bernaudin JF et al. Expression of the neutrophil elastase gene during human bone marrow cell differentiation. J Exp Med 1989; 169: 833-845.
25. Gullberg U, Bengtsson N, Bulow E et al. Processing and targeting of granule proteins in human neutrophils. J Immunol Methods 1999; 232: 201-210.
26. Borregaard N, Cowland JB. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 1997; 89: 3503-3521.
27. Lehrer RI, Ganz T. Antimicrobial polypeptides of human neutrophils. Blood 1990; 76: 2169-2181.
28. Lehr HA, Arfors KE. Mechanisms of tissue damage by leukocytes. Curr Opin Hematol 1994; 1: 92-99.
29. Stockley RA. Neutrophils and the pathogenesis of COPD. Chest 2002; 121: 151S-155S.
30. Tkalcevic J, Novelli M, Phylactides M et al. Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G. Immunity 2000; 12: 201-210.
31. Belaaouai A, McCarthy R, Baumann M et al. Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis. Nat Med 1998; 4: 615-618.
32. Morris EC, Carrell RW, Coughlin PB. Intracellular serpins in haemopoietic and peripheral blood cells. Br J Haematol 2001; 115: 758-766.
33. Aprikyan A, Oganesian A, Dale D. Aberrant subcellular localization of neutrophil elastase in cyclic neutropenia (abstract. Blood 2003; 100: 80a-81a.
34. Li FQ, Horwitz M. Characterization of mutant neutrophil elastase in severe congenital neutropenia. J Biol Chem 2001; 276: 14230-14241.
35. Grenda DS, Johnson SE, Mayer JR et al. Mice expressing a neutrophil elastase mutation derived from patients with severe congenital neutropenia have normal granulopoiesis. Blood 2002; 100: 3221-3228.
36. Aprikyan AA, Liles WC, Rodger E et al. Impaired survival of bone marrow hematopoietic progenitor cells in cyclic neutropenia. Blood 2001; 97: 147-153.
37. Belmokhtar CA, Torriglia A, Counis MF et al. Nuclear translocation of a leukocyte elastase inhibitor/elastase complex during staurosporine-induced apoptosis: role in the generation of nuclear L-DNase II activity. Exp Cell Res 2000; 254: 99-109.
38. Ancliff PJ, Gale RE, Somervaille TC et al. Complete inhibition of neutrophil elastase fails to correct the in vitro phenotype of severe congenital neutropenia (abstract). Blood 2002; 100: 243.
39. Alter BP, Young NS. The bone marrow failure syndromes. In: Nathan DG, Orkin SH, eds. Nathan and Oski's Hematology of Infancy and Childhood. Philadelphia: WB Saunders Company; 1998: 306.
40. Dale DC, Bonilla MA, Davis MW et al. A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood 1993; 81: 2496-2502.
41. Freedman MH, Alter BP. Risk of myelodysplastic syndrome and acute myeloid leukemia in congenital neutropenias. Semin Hematol 2002; 39: 128-133.
42. Zeidler C, Welte K, Barak Y et al. Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation. Blood 2000; 95: 1195-1198.
43. Ancliff PJ, Gale RE, Liesner R, Hann IM, Linch DC. Long-term follow-up of G-CSF receptor mutations in patients with severe congenital neutropenia: implications for leukaemogenesis and therapy. Br J Haematol 2003; 120: 685-690.
44. Freedman MH, Bonilla MA, Fier C et al. Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy. Blood 2000; 96: 429-436.
45. Kalra R, Dale D, Freedman M et al. Monosomy 7 and activating RAS mutations accompany malignant transformation in patients with congenital neutropenia. Blood 1995; 86: 4579-4586.
46. Bernard T, Gale RE, Evans JP, Linch DC. Mutations of the granulocyte-colony stimulating factor receptor in patients with severe congenital neutropenia are not required for transformation to acute myeloid leukaemia and may be a bystander phenomenon. Br J Haematol 1998; 101: 141-149.
47. McLemore ML, Poursine-Laurent J, Link DC. Increased granulocyte colony-stimulating factor responsiveness but normal resting granulopoiesis in mice carrying a targeted granulocyte colony-stimulating factor receptor mutation derived from a patient with severe congenital neutropenia. J Clin Invest 1998; 102: 483-492.
48. Hermans MH, Antonissen C, Ward AC et al. Sustained receptor activation and hyperproliferation in response to granulocyte colony-stimulating factor (G-CSF) in mice with a severe congenital neutropenia/acute myeloid leukemia-derived mutation in the G-CSF receptor gene. J Exp Med 1999; 189: 683-692.
49. Jeha S, Chan KW, Aprikyan AG et al. Spontaneous remission of granulocyte colony-stimulating factor-associated leukemia in a child with severe congenital neutropenia. Blood 2000; 96: 3647-3649.
50. Dale DC, Bolyard AA, Aprikyan A. Cyclic neutropenia. Semin Hematol 2002; 39: 89-94.
51. Palmblad JE, dem Borne AE. Idiopathic, immune, infectious, and idiosyncratic neutropenias. Semin Hematol 2002; 39: 113-120.
52. Dror Y, Freedman MH. Shwachman-Diamond syndrome. Br J Haematol 2002; 118: 701-713.
53. Dror Y, Freedman MH. Shwachman-Diamond syndrome: an inherited preleukemic bone marrow failure disorder with aberrant hematopoietic progenitors and faulty marrow microenvironment. Blood 1999; 94: 3048-3054.
54. Dror Y, Freedman MH. Shwachman-Diamond syndrome marrow cells show abnormally increased apoptosis mediated through the Fas pathway. Blood 2001; 97: 3011-3016.
55. Dror Y, Ginzberg H, Dalal I et al. Immune function in patients with Shwachman-Diamond syndrome. Br J Haematol 2001; 114: 712-717.
56. Boocock GR, Morrison JA, Popovic M et al. Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat Genet 2003; 33: 97-101.
57. Mack DR, Forstner GG, Wilschanski M, Freedman MH, Durie PR. Shwachman syndrome: exocrine pancreatic dysfunction and variable phenotypic expression. Gastroenterology 1996; 111: 1593-1602.
58. Ginzberg H, Shin J, Ellis L et al. Shwachman syndrome: phenotypic manifestations of sibling sets and isolated cases in a large patient cohort are similar. J Pediatr 1999; 135: 81-88.
59. Dror Y, Durie P, Ginzberg H et al. Clonal evolution in marrows of patients with Shwachman-Diamond syndrome: a prospective 5-year follow-up study. Exp Hematol 2002; 30: 659-669.
60. Cunningham J, Sales M, Pearce A et al. Does isochromosome 7q mandate bone marrow transplant in children with Shwachman-Diamond syndrome. Br J Haematol 2002; 119: 1062-1069.
61. Kannourakis G. Glycogen storage disease. Semin Hematol 2002; 39: 103-106.
62. Matern D, Starzl TE, Arnaout W et al. Liver transplantation for glycogen storage disease types I, III, and IV. Eur J Pediatr 1999; 158(suppl 2): S43-S48.
63. Calderwood S, Kilpatrick L, Douglas SD et al. Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type Ib. Blood 2001; 97: 376-382.
64. Dieckgraefe BK, Korzenik JR, Husain A, Dieruf L. Association of glycogen storage disease Ib and Crohn disease: results of a North American survey. Eur J Pediatr 2002; 161(suppl 2): S88-S92.
65. Pinsk M, Burzynski J, Yhap M et al. Acute myelogenous leukemia and glycogen storage disease Ib. J Pediatr Hematol Oncol 2002; 24: 756-758.
66. Cham B, Bonilla MA, Winkelstein J. Neutropenia associated with primary immunodeficiency syndromes. Semin Hematol 2002; 39: 107-112.
67. Levy J, Espanol-Boren T, Thomas C et al. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 1997; 131: 47-54.
68. Solanilla A, Dechanet J, El Andaloussi A et al. CD40-ligand stimulates myelopoiesis by regulating flt3-ligand and thrombopoietin production in bone marrow stromal cells. Blood 2000; 95: 3758-3764.
69. Devriendt K, Kim AS, Mathijs G et al. Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat Genet 2001; 27: 313-317.
70. Ancliff PJ, Blundell MP, Gale RE et al. Activating mutations in the Wiskott Aldrich syndrome protein may define a sub-group of severe congenital neutropenia with specific and unusual laboratory features [abstract]. Blood 2001; 98: 439.
71. Aprikyan AA, Liles WC, Park JR et al. Myelokathexis, a congenital disorder of severe neutropenia characterized by accelerated apoptosis and defective expression of bcl-x in neutrophil precursors. Blood 2000; 95: 320-327.
72. Pearson HA, Lobel JS, Kocoshis SA et al. A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. J Pediatr 1979; 95: 976-984.
73. Rotig A, Cormier V, Blanche S et al. Pearson's marrow-pancreas syndrome. A multisystem mitochondrial disorder in infancy. J Clin Invest 1990; 86: 1601-1608.
74. Barth PG, Scholte HR, Berden JA et al. An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes. J Neurol Sci 1983; 62: 327-355.
75. Zeidler C, Barth PG, Bonilla MA et al. Neutropenia in Barth syndrome: clinical course and treatment of neutropenia [abstract]. Blood 2001; 98: 300.
76. Bione S, D'Adamo P, Maestrini E et al. A novel X-linked gene, G4.5. is responsible for Barth syndrome. Nat Genet 1996; 12: 385-389.
77. McMillin JB, Dowhan W. Cardiolipin and apoptosis. Biochim Biophys Acta 2002; 1585: 97-107.